senyawa 4-aminokuinolin yang berkhasiat anti-inflamasi dan antiprotozoa.
|Trade names||Amdaquine, Amobin, others|
|AHFS/Drugs.com||International Drug Names|
|ATC code||P01BA06 (WHO)|
Systematic (IUPAC) name: 4-[(7-chloroquinolin-4-yl)amino]-2-[(diethylamino)methyl]phenol
|Chemical and physical data|
|Molar mass||355.861 g/mol|
|3D model (Jmol)||Interactive image|
Amodiaquine (ADQ) is a medication used to treat malaria, including Plasmodium falciparum malaria when uncomplicated. It is recommended to be given with artesunate to reduce the risk of resistance. Due to the risk of rare but serious side effects, it is not generally recommended to prevent malaria.
The side effects of amodiaquine are generally minor to moderate and are similar to those of chloroquine. Rarely liver problems or low blood cell levels may occur. When taken in excess headaches, trouble seeing, seizures, and cardiac arrest may occur. While not extensively studied as of 2007, it appeared to be safe in pregnancy. Amodiaquine is a 4-aminoquinoline compound related to chloroquine.
Amodiaquine was first made in 1948. It is on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system. The wholesale cost is about 0.01 USD per dose as of 2014. While not avaliable in the United States, it is widely available in Africa.